Pharmacokinetic Study of Levetiracetam in Children
Open Access
- 1 December 2001
- Vol. 42 (12) , 1574-1579
- https://doi.org/10.1046/j.1528-1157.2001.41300.x
Abstract
Summary: Purpose: The pharmacokinetics of the novel antiepileptic drug (AED) levetiracetam and its major metabolite, ucb L057, were studied in children with partial seizures in a multicenter, open‐...Keywords
This publication has 11 references indexed in Scilit:
- Efficacy and Tolerability of Levetiracetam 3000 mg/d in Patients with Refractory Partial Seizures: A Multicenter, Double‐Blind, Responder‐Selected Study Evaluating MonotherapyEpilepsia, 2000
- Multicenter Double‐Blind, Randomized, Placebo‐Controlled Trial of Levetiracetam as Add‐On Therapy in Patients with Refractory Partial SeizuresEpilepsia, 2000
- Levetiracetam for partial seizuresNeurology, 2000
- A multicentre, double-blind, randomized, parallel group study to evaluate the tolerability and efficacy of two oral doses of levetiracetam, 2000 mg daily and 4000 mg daily, without titration in patients with refractory epilepsySeizure, 2000
- Pharmacokinetic profile of levetiracetamPharmacology & Therapeutics, 2000
- Managing Pediatric Epilepsy Syndromes With New Antiepileptic DrugsPublished by American Academy of Pediatrics (AAP) ,1999
- A study of topiramate pharmacokinetics and tolerability in children with epilepsyPediatric Neurology, 1999
- Population‐Based Investigation of Valproic Acid Relative Clearance Using Nonlinear Mixed Effects Modeling: Influence of Drug‐Drug Interaction and Patient CharacteristicsThe Journal of Clinical Pharmacology, 1997
- Cognitive effects of a new pyrrolidine derivative (levetiracetam) in patients with epilepsyProgress in Neuro-Psychopharmacology and Biological Psychiatry, 1995
- Analytical Methods Validation: Bioavailability, Bioequivalence, and Pharmacokinetic StudiesJournal of Pharmaceutical Sciences, 1992